MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0219487
Innoterra Bioscience Private Limited - information technology in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹1.21 Cr
▼ 41% YoY
Net loss · FY 2023
₹1.96 Cr
Net margin -162.5%
EBITDA · FY 2023
-₹1.9 Cr
EBITDA margin -157.1%
Authorised capital
₹16.5 Cr
Registered with MCA
Paid-up capital
₹15.88 Cr
Issued & subscribed
Satisfied charges
₹15 Lakh
No open charges
Company age
16 yrs
Est. 2010
Directors on board
3
As per MCA filings
About Innoterra Bioscience Private Limited
Data last updated:
Innoterra Bioscience Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Innoterra Platforms Holding Ag. It operates in the IT consulting and support services segment of the technology and IT services sector. It was incorporated on 02 July 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U20211MH2010PTC205170. Its GSTIN is 27AABCL8825G1ZD (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹16.5 Cr and a paid-up capital of ₹15.88 Cr. It was formerly known as Innoterra Tech India Private Limited and Lateral Praxis (India) Private Limited. It is led by directors including Kasinathan Krishna Kumar Avinash and Ankur Tripathi.
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.21 Cr, a decline of 41% compared to the previous year. For the same year it recorded a net loss of ₹1.96 Cr (net margin -162.5%) and EBITDA of -₹1.9 Cr (EBITDA margin -157.1%). Revenue has declined at a compounded annual rate (CAGR) of 17% over three years and 10% over five years.
The company is associated with 2 brands: Lateral Praxis and Innoterra. As per MCA filings, the company has satisfied charges of ₹15 Lakh on record. The company has 4 deals on record (2 secondary share transfers, 1 acquisition, 1 funding round), with disclosed funding of ₹40 Lakh; the latest was in May 2020. The company has 6 MSME Form 1 returns on record between 2022 and 2023, listing 32 overdue payments to 1 micro and small supplier.
Innoterra Bioscience Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0219487). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website innoterra.com.
Company details
CIN U20211MH2010PTC205170
Registration Number 205170
Incorporation Date 02 July 2010
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 22 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Innoterra Platforms Holding Ag
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0219487
Name history
Innoterra Bioscience has undergone 2 name changes throughout its history. The company was previously known as Innoterra Tech India Private Limited, and Lateral Praxis (India) Private Limited. The current legal name is Innoterra Bioscience Private Limited.
| Company Name | Status |
|---|---|
| Innoterra Bioscience Private Limited | Current |
| Innoterra Tech India Private Limited | Previous |
| Lateral Praxis (India) Private Limited | Previous |
CIN history
Innoterra Bioscience has one previous CIN (Corporate Identification Number): U72200MH2010PTC205170. The current CIN is U20211MH2010PTC205170, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U20211MH2010PTC205170 | Current |
| U72200MH2010PTC205170 | Previous |
Key People
Kasinathan Krishna Kumar Avinash Director Ankur Tripathi Additional Director Shubhda Nautiyal Additional Director Recognitions & Rankings of Innoterra Bioscience
Contact details
Innoterra Bioscience Private Limited's registered office is in Mumbai, Maharashtra. Its website is innoterra.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressUnit 801 – 802 8th Floor Tower 1 One International Center, Senapati Bapat Marg Prabhadevi, Mumbai, Maharashtra, India – 400013
- IndustryInformation Technology, IT Consulting & Support Services
To see the full contact details of Innoterra Bioscience Private Limited, buy the company report.
Comprehensive company report
Innoterra Bioscience Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Innoterra Bioscience operates two associated brands: Lateral Praxis and Innoterra. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Farming, IT, and e-governance services are provided to farmers. | lateralpraxis.com | |
| Innoterra is engaged in agri-tech innovation and food supply chain solutions. | innoterra.com |
Business activity
The main business activities of Innoterra Bioscience are information and communication and manufacturing. In detail, this covers computer programming, consultancy and related activities and chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| J | Information and communication | J6 | Computer programming, consultancy and related activities | |
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Innoterra Bioscience Private Limited, buy the company report.
Financials of Innoterra Bioscience Private Limited
FY 2025 filings availableInnoterra Bioscience Private Limited reported revenue of ₹1.21 Cr (down 41% YoY) for FY 2023.
Revenue · FY 2023
₹1.21 Cr ▼ 41%
Net loss · FY 2023
₹1.96 Cr margin -162.5%
EBITDA · FY 2023
-₹1.9 Cr margin -157.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 41%
3 years · compounded
▼ 17%
5 years · compounded
▼ 10%
Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 41% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1.21 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.9 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.96 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -157.1% | ||||
| Net Profit Margin | -162.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Innoterra Bioscience Private Limited, buy the company report.
Board of directors of Innoterra Bioscience Private Limited
Innoterra Bioscience has 3 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kasinathan Krishna Kumar Avinash Also directs: Districo India Private Limited, Innoterra Private Limited, Innoterra India Private Limited and 1 more | Director | 12 Jul 2024 | 2 Years 3 Months | Current |
| Ankur Tripathi | Additional Director | 30 Jul 2025 | 1 Years 3 Months | Current |
| Shubhda Nautiyal | Additional Director | 01 Aug 2025 | 1 Years 3 Months | Current |
Auditor
Innoterra Bioscience Private Limited is audited by A K KOCCHAR & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A K KOCCHAR & ASSOCIATES | FY 2023 | 0120410W |
Shareholding
The shareholding of Innoterra Bioscience Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Innoterra Bioscience Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹15 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Dec 2011 | 10331940 | Bank of India | ₹15 Lakh | Satisfied |
To see the full charge records of Innoterra Bioscience Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Innoterra Bioscience Private Limited has 4 deals on record (2 secondary share transfers, 1 acquisition, 1 funding round), with disclosed funding of ₹40 Lakh; the latest was in May 2020.
Total deals
4
Secondary share transfers
2
Acquisition
1
Funding round
1
Disclosed funding
₹40 Lakh
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2020 | Acquisition | ₹6.32 Cr | Buyer: Pioneering Ventures |
| Dec 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Dec 2010 | Funding round | ₹40 Lakh | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Innoterra Bioscience Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Innoterra Bioscience Private Limited has 6 MSME Form 1 returns on record between 2022 and 2023, listing 32 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Cxio Technologies Pvt Ltd |
To see the full MSME payment records of Innoterra Bioscience Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Innoterra Bioscience has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCL8825G1ZD | Maharashtra | Active | 01 Jul 2017 |
| 09AABCL8825G1ZB | Uttar Pradesh | Active | 02 Jan 2018 |
To see the full GST registrations and return filing status of Innoterra Bioscience Private Limited, buy the company report.
Recent activity
Innoterra Bioscience Private Limited has 16 board changes on record since 2010: 4 appointments and 12 cessations. The latest: Shubhda Nautiyal was appointed as Additional Director on 01 Aug 2025.
AGM
Innoterra Bioscience Private Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records.
Appointed
Shubhda Nautiyal was appointed as Additional Director.
Appointed
Ankur Tripathi was appointed as Additional Director.
Filing
Innoterra Bioscience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Kasinathan Krishna Kumar Avinash ceased to be Additional Director.
Appointed
Kasinathan Krishna Kumar Avinash was appointed as Director.
Ceased
Satyajit Sarna ceased to be Additional Director.
Ceased
Vishal Somani ceased to be Director.
Appointed
Satyajit Sarna was appointed as Director.
Ceased
Akshaya Manjunath Kamath ceased to be Director.
Ceased
Anup Subhash Karwa ceased to be Additional Director.
Ceased
Pablo Erat ceased to be Additional Director.
9 earlier events are in the company report.
News
Frequently asked questions
Innoterra Bioscience is an active private limited company based in Mumbai, Maharashtra, India. The company works in IT consulting and support services, within the information technology industry. It was incorporated on 02 July 2010 (16+ years old) and is registered under CIN U20211MH2010PTC205170.
Innoterra Bioscience has 3 current directors:
- Kasinathan Krishna Kumar Avinash - Director
- Ankur Tripathi - Additional Director
- Shubhda Nautiyal - Additional Director
The latest financial statements of Innoterra Bioscience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 22 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Innoterra Bioscience is 27AABCL8825G1ZD, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AABCL8825G1ZB (Uttar Pradesh).
The CIN (Corporate Identification Number) of Innoterra Bioscience is U20211MH2010PTC205170. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Innoterra Bioscience was incorporated on 02 July 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
Innoterra Bioscience has 4 deals on record (2 secondary share transfers, 1 acquisition, 1 funding round), with disclosed funding of ₹40 Lakh; the latest was in May 2020.
Shubhda Nautiyal was appointed as Additional Director on 01 Aug 2025. Ankur Tripathi was appointed as Additional Director on 30 Jul 2025. Kasinathan Krishna Kumar Avinash ceased to be Additional Director on 11 Sep 2024. Innoterra Bioscience has 16 board changes on record in total.
Yes, Innoterra Bioscience is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0219487).
Innoterra Bioscience has 6 MSME Form 1 returns on record between 2022 and 2023, listing 32 overdue payments to 1 micro and small supplier. The latest return was filed on 18 Nov 2023.
Innoterra Bioscience can be reached through the website innoterra.com. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages